ATE277075T1 - Tripeptidische verbindungen mit wirksamkeit als selektive inhibitoren der aminopeptidase a und sie enthaltende pharmazeutische zusammensetzungen - Google Patents
Tripeptidische verbindungen mit wirksamkeit als selektive inhibitoren der aminopeptidase a und sie enthaltende pharmazeutische zusammensetzungenInfo
- Publication number
- ATE277075T1 ATE277075T1 AT00900616T AT00900616T ATE277075T1 AT E277075 T1 ATE277075 T1 AT E277075T1 AT 00900616 T AT00900616 T AT 00900616T AT 00900616 T AT00900616 T AT 00900616T AT E277075 T1 ATE277075 T1 AT E277075T1
- Authority
- AT
- Austria
- Prior art keywords
- alkyl
- cycloalkyl
- group
- heterocycloalkyl
- aminoopeptidase
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 229940124639 Selective inhibitor Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 12
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 8
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 4
- 125000000592 heterocycloalkyl group Chemical group 0.000 abstract 4
- 229910018828 PO3H2 Inorganic materials 0.000 abstract 3
- 229910006069 SO3H Inorganic materials 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 3
- -1 guanidinyl Chemical group 0.000 abstract 3
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 abstract 3
- 229910006074 SO2NH2 Inorganic materials 0.000 abstract 2
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 125000003831 tetrazolyl group Chemical group 0.000 abstract 2
- 125000006528 (C2-C6) alkyl group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004404 heteroalkyl group Chemical group 0.000 abstract 1
- 150000002391 heterocyclic compounds Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9900587A FR2788526B1 (fr) | 1999-01-20 | 1999-01-20 | Composes tripeptidiques utiles a titre d'hinhibiteurs selectifs de l'aminopeptidase a et compositions pharmaceutiques correspondantes |
| PCT/FR2000/000112 WO2000043414A1 (fr) | 1999-01-20 | 2000-01-19 | Composes tripeptidiques utiles a titre d'inhibiteurs selectifs de l'aminopeptidase a et compositions pharmaceutiques correspondantes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE277075T1 true ATE277075T1 (de) | 2004-10-15 |
Family
ID=9541040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00900616T ATE277075T1 (de) | 1999-01-20 | 2000-01-19 | Tripeptidische verbindungen mit wirksamkeit als selektive inhibitoren der aminopeptidase a und sie enthaltende pharmazeutische zusammensetzungen |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20020061840A1 (de) |
| EP (1) | EP1140981B1 (de) |
| JP (1) | JP2003506313A (de) |
| AT (1) | ATE277075T1 (de) |
| CA (1) | CA2359096A1 (de) |
| DE (1) | DE60014029T2 (de) |
| FR (1) | FR2788526B1 (de) |
| WO (1) | WO2000043414A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6777443B2 (en) | 2001-05-15 | 2004-08-17 | Novartis Ag | Dipeptide derivatives |
| US20030165574A1 (en) * | 2002-03-01 | 2003-09-04 | Ward Loren Spencer | Compositions and methods for treatment of body weight conditions |
| WO2005077401A1 (fr) * | 2004-02-09 | 2005-08-25 | Jianrong Miao | Cardiotonique contenant un tripeptide ou un derive de celui-ci en tant qu'ingredient actif |
| KR100641076B1 (ko) | 2004-08-27 | 2006-11-02 | 연세대학교 산학협력단 | 신규한 아미노펩티다아제 n 억제제 |
| WO2007141005A1 (en) * | 2006-06-09 | 2007-12-13 | Bayer Healthcare Ag | Use of glutamyl aminopeptidase (enpep) as a therapeutic or diagnostic target |
| FR2931151A1 (fr) * | 2008-05-13 | 2009-11-20 | Pharmaleads Soc Par Actions Si | Nouveaux derives d'amino-acides, leur procede de preparation et leur utilisation therapeutique |
| EP2326619B1 (de) | 2008-08-01 | 2019-02-27 | Bioxiness Pharmaceuticals, Inc. | Methioninanaloga und verfahren zu deren anwendung |
| WO2018151285A1 (ja) * | 2017-02-20 | 2018-08-23 | 学校法人順天堂 | 掻痒性皮膚疾患の予防又は治療薬 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4636560A (en) * | 1984-11-16 | 1987-01-13 | E. R. Squibb & Sons, Inc. | Amino thiol peptides |
| FR2770844A1 (fr) * | 1997-11-10 | 1999-05-14 | Inst Nat Sante Rech Med | Inhibiteurs de toxines clostridiales et compositions pharmaceutiques les contenant |
-
1999
- 1999-01-20 FR FR9900587A patent/FR2788526B1/fr not_active Expired - Fee Related
-
2000
- 2000-01-19 DE DE60014029T patent/DE60014029T2/de not_active Expired - Fee Related
- 2000-01-19 WO PCT/FR2000/000112 patent/WO2000043414A1/fr not_active Ceased
- 2000-01-19 AT AT00900616T patent/ATE277075T1/de not_active IP Right Cessation
- 2000-01-19 JP JP2000594830A patent/JP2003506313A/ja active Pending
- 2000-01-19 CA CA002359096A patent/CA2359096A1/fr not_active Abandoned
- 2000-01-19 EP EP00900616A patent/EP1140981B1/de not_active Expired - Lifetime
-
2001
- 2001-07-20 US US09/908,977 patent/US20020061840A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000043414A1 (fr) | 2000-07-27 |
| FR2788526A1 (fr) | 2000-07-21 |
| EP1140981B1 (de) | 2004-09-22 |
| EP1140981A1 (de) | 2001-10-10 |
| US20020061840A1 (en) | 2002-05-23 |
| JP2003506313A (ja) | 2003-02-18 |
| CA2359096A1 (fr) | 2000-07-27 |
| DE60014029T2 (de) | 2005-10-06 |
| DE60014029D1 (de) | 2004-10-28 |
| FR2788526B1 (fr) | 2002-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA04001258A (es) | Activador para el receptor d que responde al proliferador de peroxisoma. | |
| MXPA02002720A (es) | Nuevos compuestos de alfa-aminoacido-sulfonilo, un proceso para su preparacion y composiciones farmaceuticas que los comprenden. | |
| CA2432713A1 (en) | Aniline derivatives or salts thereof and cytokine production inhibitors containing the same | |
| DE60212867D1 (de) | Thiazolylsubstituierte aminopyrimidine als pflanzenschutzmittel | |
| BRPI0213243B8 (pt) | composto heterocíclico aromático contendo um anel oxazol, tiazol ou imidazol, ou um sal farmaceuticamente aceitável do mesmo, e, composição farmacêutica | |
| CR7727A (es) | Compuestos quimicos | |
| GEP20074148B (en) | Pyrrolo-triazine aniline compounds useful as kinase inhibitors | |
| HUP9802822A2 (hu) | Halogén-benzimidazol-származékok, intermedierjeik, előállításuk és a vegyületeket hatóanyagként tartalmazó mikrobicid készítmények | |
| PT976748E (pt) | Derivados de pirrolidina com actividade inibidora de fosfolipase a2 | |
| DK1300401T3 (da) | Thiazolderivater til anvendelse som antiinflammatoriske midler | |
| ATE277075T1 (de) | Tripeptidische verbindungen mit wirksamkeit als selektive inhibitoren der aminopeptidase a und sie enthaltende pharmazeutische zusammensetzungen | |
| DE60125053D1 (de) | Cephem verbindungen und diese enthaltende esbl nachweisreagenzien | |
| NO995289D0 (no) | Benzimidazol-derivater | |
| MXPA04005837A (es) | Nuevos derivados de benzotiazina y benzotiadiazina, metodo para su preparacion y composiciones farmaceuticas que los contienen. | |
| ATE502034T1 (de) | Thiazolidindionderivate und diese enthaltende pharmazeutische zusammensetzung | |
| EP1197211A4 (de) | Wirkstoffe zur vorbeugung und behandlung von krebs | |
| MXPA04005839A (es) | Nuevos compuestos de benzotiazina y benzotiadiazina un proceso para su preparacion y las composiciones farmaceuticas que los contienen. | |
| EP1142868A4 (de) | Amidderivate | |
| NO20053302D0 (no) | Imidazolderivater med affinitet for alfa 2-reseptoraktivitet. | |
| NO20041250L (no) | Vannopploselige fenylpyridazinderivater og medikamenter inneholdende disse. | |
| TW200510350A (en) | Sulfonamide derivatives having isoxazole ring | |
| DK1097145T3 (da) | Polyhydroxyalkylpyrazinderivater, deres fremstilling og lægemidler indeholdende disse derivater | |
| ECSP982623A (es) | Derivados del 2-( 4-aril - o heteroaril - piperazin -1- ilmetil) -1h-indol | |
| TH61366A (th) | ตัวยับยั้งแคสเปสและการใช้ตัวยับยั้งเหล่านี้ | |
| TH84138A (th) | สารประกอบ n- ฟอร์มิล ไฮดรอกซีลามีน |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |